Ticker: CVX | Earnings Date: July 31, 2026 (Before Market Open) | Prepared: July 31, 2026
Reporting Period: Q2 2026 (quarter ended June 30, 2026) | Sector ETF Benchmark: XLE (Energy Select Sector SPDR)
Key Takeaway: Setup leans toward a beat — consensus has been revised down sharply since Q1 earnings, oil prices averaged well above the $70 Brent guidance assumption through much of Q2, and management's own commentary pointed to higher production, unwinding of ~$1B in paper derivative positions, and continued downstream integration value capture; the biggest swing factor is free cash flow quality after Q1's negative reported FCF spooked the market.
Heading into Q2 2026, the bar for CVX looks manageable: consensus operating EPS of ~$5.65 is up sharply from Q1's $1.41 actual (reflecting the full-quarter benefit of higher oil prices and the unwinding of ~$1 billion in paper derivative positions that management flagged on the Q1 call), yet the as-of-May-6 baseline was only $4.90, meaning estimates have been revised up ~15% since the last print — a trajectory that typically signals the street is chasing rather than getting ahead of the company. Management's tone at both the Bernstein (May 28) and JP Morgan (June 23) conferences was notably confident: WTI was at $89/bbl at Bernstein, management guided to "more upward pressure" on physical prices into June and July as inventory buffers were drawn down, and the Microsoft West Texas power project FID was framed as a pre-year-end catalyst. The stock has underperformed both XLE (+0.2%) and the S&P 500 (+2.9%) since Q1 earnings, returning only +0.9% on a base of 100, with a sharp mid-June selloff (CVX touched ~$165 on June 30) before recovering to ~$192 — suggesting the market has not yet priced in a clean beat. The wildcard is reported free cash flow: Q1's negative FCF print (driven by working capital timing) was the primary source of post-earnings disappointment, and any repeat of that dynamic — even if adjusted FCF is strong — risks a muted or negative stock reaction despite solid underlying results.
Key Takeaway: Consensus is a low-to-moderate bar heading into Q2 — estimates have been revised up ~15% since the Q1 print on higher oil prices, but remain well below what elevated Brent/WTI through much of the quarter could deliver; free cash flow is the bigger swing factor given Q1's negative reported FCF and management's explicit guidance for the ~$1B paper position unwind to benefit Q2.
Table 1 — Q2 2026 Current Quarter Snapshot
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | Guidance | Consensus vs. Guidance |
Adj. EPS (Diluted Operating) ($) | $1.41 | $1.77 | $5.65 | +219% YoY | No specific Q2 EPS guidance; FY2026 FCF guided at $6B at $70 Brent | N/A (no quarterly EPS guidance) |
Revenue — Sales & Other Operating ($B) | $47.6B | $44.4B | $55.1B | +24% YoY | No specific quarterly revenue guidance | N/A |
Free Cash Flow ($B) | -$1.5B (reported); adj. positive | $4.9B | $14.8B | +204% YoY | $6B FY2026 at $70 Brent (unchanged) | FY consensus $34.2B vs. $6B Q guidance (different basis) |
Production — Worldwide (Mboe/d) | 3,858.5 Mboe/d | 3,395.2 Mboe/d | 4,029.8 Mboe/d | +19% YoY | FY2026 +7–10% YoY; Q2 expected higher than Q1 | Consensus ~4,030 Mboe/d vs. implied guidance midpoint ~4,000 Mboe/d; ~+0.7% above |
Capital Expenditure ($B) | $4.1B | $3.7B | $4.5B | +22% YoY | $18–19B FY2026 (on track) | FY consensus $18.1B vs. $18–19B guidance; within range |
Operating EBITDA ($B) | $10.7B | $9.3B | $24.7B | +166% YoY | No specific quarterly EBITDA guidance | N/A |
Source: Visible Alpha Consensus and Actuals Data. Q2 2026 consensus as of July 31, 2026. Q1 2026 actuals as reported May 1, 2026. Note: Q2 2026 Operating EBITDA consensus of $24.7B reflects the full-quarter benefit of elevated oil prices (WTI averaged ~$85–90/bbl through much of Q2) vs. Q1's $10.7B which was impacted by timing effects. The large sequential jump in FCF consensus ($14.8B vs. -$1.5B) reflects the expected unwind of ~$1B in paper derivative positions and normalization of working capital flagged by management on the Q1 call.
Table 2 — Beat/Miss History: Top 2 KPIs (Last 8 Quarters)
Quarter | KPI | Reported | Consensus | Surprise % | Result |
Q1 2026 | Adj. EPS ($) | $1.41 | $1.02 | +38.2% | BEAT |
Q1 2026 | Production (Mboe/d) | 3,858.5 | 3,852.5 | +0.2% | BEAT |
Q4 2025 | Adj. EPS ($) | $1.52 | $1.44 | +5.6% | BEAT |
Q4 2025 | Production (Mboe/d) | 4,045.0 | 3,993.8 | +1.3% | BEAT |
Q3 2025 | Adj. EPS ($) | $1.86 | $1.70 | +9.4% | BEAT |
Q3 2025 | Production (Mboe/d) | 4,084.8 | 3,872.7 | +5.5% | BEAT |
Q2 2025 | Adj. EPS ($) | $1.77 | $1.70 | +4.1% | BEAT |
Q2 2025 | Production (Mboe/d) | 3,395.2 | 3,341.7 | +1.6% | BEAT |
Q1 2025 | Adj. EPS ($) | $2.18 | $2.13 | +2.3% | BEAT |
Q1 2025 | Production (Mboe/d) | 3,352.7 | 3,302.4 | +1.5% | BEAT |
Q4 2024 | Adj. EPS ($) | $2.06 | $2.15 | -4.2% | MISS |
Q4 2024 | Production (Mboe/d) | 3,349.3 | 3,316.0 | +1.0% | BEAT |
Q3 2024 | Adj. EPS ($) | $2.51 | $2.46 | +2.0% | BEAT |
Q3 2024 | Production (Mboe/d) | 3,364.0 | 3,279.8 | +2.6% | BEAT |
Q2 2024 | Adj. EPS ($) | $2.55 | $2.98 | -14.4% | MISS |
Q2 2024 | Production (Mboe/d) | 3,291.8 | 3,224.2 | +2.1% | BEAT |
Pattern: CVX has beaten adjusted EPS consensus in 6 of the last 8 quarters and beaten production consensus in 7 of 8 quarters, with the two EPS misses (Q2 2024 and Q4 2024) driven by one-time items and commodity timing rather than operational underperformance. Production beats have been consistent and accelerating post-Hess integration.
Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: All 2026 full-year guidance metrics were reaffirmed unchanged at Q1 earnings (May 1); the only post-earnings update was a material raise in Q2 affiliate distribution guidance (>$2B above Q1 levels) driven by TCO shifting to monthly dividends — a positive read-through for Q2 FCF quality.
Metric | Initial Guidance (Q1 2026 Earnings Call, May 1) | Revised Guidance | Current Consensus | Note |
FY2026 Production Growth | +7% to +10% YoY | — | ~4,025 Mboe/d FY avg. (consensus) | Reaffirmed; Q2 production guided higher than Q1 (3,858 Mboe/d) |
FY2026 Capital Expenditure | $18B–$19B | — | $18.1B (consensus) | Reaffirmed; Microsoft power project capex already factored into existing guidance (confirmed at JPM Conf., June 23) |
FY2026 Structural Cost Reductions | $3B–$4B by year-end | — | On track per management | Reaffirmed at Bernstein (May 28) and JPM (June 23); >60% from durable efficiency gains |
FY2026 Free Cash Flow | $6B at $70 Brent (unchanged) | — | $34.2B FY consensus (different basis — reflects higher realized prices) | Guidance at $70 Brent; management noted "a lot of upside" if prices unfold higher; WTI was ~$89 at Bernstein (May 28) |
Q2 Equity Affiliate Distributions | Raised >$2B above Q1 levels at Q1 earnings call | — | N/A (not separately tracked in consensus) | ↑ Raised at Q1 earnings (May 1); TCO shifted to monthly dividends; first payment received in April; CPChem and Angola LNG also contributing |
Q2 Downstream Integration Value Capture | Continuing into Q2 and "likely beyond"; global equity crude throughput to more than double YoY to 40%; Asia refineries to run >40% CVX equity crude | — | N/A | Positive tone; management framed as structural competitive advantage from Hess integration, not one-time |
Microsoft Power Project (West Texas) | Advanced negotiations; no definitive agreement or FID; multi-gigawatt scale; customer bears commodity price risk | FID expected before year-end 2026 (JPM Conf., June 23) | N/A | ↑ Tone more definitive at JPM (June 23): FID timeline set, capex already in guidance, Q2 call flagged as venue for more detail; management described as "excited and confident" |
Key Takeaway: Estimates have been revised up ~15% for Q2 2026 EPS and ~17% for FY2026 FCF since the Q1 print baseline (May 6, 2026), tracking the sharp move higher in oil prices through the quarter; the gap between FY consensus FCF ($34.2B) and management's $6B guidance (at $70 Brent) is not a risk — it reflects the different price assumption, with realized Brent averaging well above $70 through Q2.
KPI (Period) | Estimate (May 6, 2026 — 5 Days Post Q1 Print) | Current Consensus (Jul 31, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Adj. EPS — Q2 2026 | $4.90 | $5.65 | +15.3% | No quarterly EPS guidance | No quarterly EPS guidance | N/A | N/A |
Adj. EPS — FY2026 | $13.64 | $14.93 | +9.5% | No FY EPS guidance | No FY EPS guidance | N/A | N/A |
Production — Q2 2026 (Mboe/d) | 4,023.2 | 4,029.8 | +0.2% | Higher than Q1 (3,858 Mboe/d); FY +7–10% | Unchanged | Unchanged | ~+0.7% above implied midpoint |
Production — FY2026 (Mboe/d) | 4,010.4 | 4,024.7 | +0.4% | FY +7–10% YoY (vs. ~3,750 Mboe/d in 2025) | Unchanged | Unchanged | Within guidance range |
Free Cash Flow — Q2 2026 ($B) | $12.6B | $14.8B | +17.5% | $6B FY at $70 Brent | Unchanged | Unchanged | Consensus well above $70 Brent guidance (reflects higher realized prices) |
Free Cash Flow — FY2026 ($B) | $32.5B | $34.2B | +5.2% | $6B at $70 Brent | Unchanged | Unchanged | Consensus reflects ~$85–90 Brent assumption; not a guidance miss |
CapEx — FY2026 ($B) | $18.1B | $18.1B | 0.0% | $18–19B | Unchanged | Unchanged | At low end of guidance; capital discipline intact |
Source: Visible Alpha Consensus and Actuals Data. May 6, 2026 baseline = 5 trading days post Q1 2026 earnings (May 1, 2026). Estimate revisions are tracking higher oil prices rather than diverging from guidance — the gap between FY consensus FCF ($34.2B) and management's $6B guidance is entirely explained by the price assumption difference ($85–90 Brent realized vs. $70 Brent guidance). Production estimates are essentially flat since the Q1 print, consistent with management's reaffirmed guidance.
Key Takeaway: CVX has significantly underperformed both the S&P 500 (+2.9%) and XLE (+0.2%) since Q1 earnings, returning only +0.9% on a base of 100 — driven by a sharp mid-June selloff (stock fell from ~$197 to ~$165 between May 19 and June 30) that was not recovered until mid-July; the underperformance appears sentiment/multiple-driven rather than earnings-driven, creating a potentially attractive setup into Q2 results.
CVX vs. XLE (Energy Select Sector SPDR) vs. S&P 500 (SPY) — Indexed to 100 at Q1 2026 Earnings Date (May 1, 2026). Source: Stock Price Data.
Key observations: (1) CVX peaked at ~$197 on May 19 (WTI near $89/bbl, Bernstein conference bullish tone) before a sharp 16% selloff through June 30 as oil prices pulled back and the market digested the geopolitical uncertainty; (2) the stock recovered strongly in July (+16% from the June 30 trough to July 24 peak of ~$195), suggesting the selloff was overdone; (3) XLE broadly tracked CVX's pattern but with less volatility, while SPY was more resilient throughout; (4) the mid-June selloff coincided with the Microsoft power deal announcement (June 22) and JPM conference (June 23), suggesting the market was not yet pricing in the power business optionality. Material events marked: Q1 Earnings (May 1), Bernstein Conference (May 28), Microsoft Power Deal Announcement (June 22), JP Morgan Conference (June 23).
Key Takeaway: Peer commentary from Q1 2026 earnings calls (May 2026) and subsequent conferences is broadly constructive for CVX's Q2 setup: XOM flagged downstream margins playing out "very well" into Q2, OXY highlighted strong Permian unconventional performance and raised midstream guidance, EOG pointed to a $60 WTI floor and $80 average over the next few years, and oilfield services peers BKR and SLB (reporting Q2 2026 results) confirmed international upstream activity is recovering with deepwater FIDs accelerating — all positive read-throughs for CVX's integrated model.
Note: All peer commentary above is sourced from Q1 2026 earnings calls (May 2026), subsequent investor conferences (May–June 2026), and Q2 2026 earnings calls (BKR July 27, SLB July 24) — all within the last 60 days and directly relevant to CVX's Q2 2026 reporting quarter. Q1 2025 earnings commentary (prior quarter results) has been excluded per the user's instruction.
Key Takeaway: The most important development since Q1 earnings is the Microsoft West Texas power project announcement (June 22) — the first concrete step toward a multi-gigawatt, non-commodity-correlated cash stream that management has been telegraphing; the Q2 call is expected to be the venue for full details, making this the single biggest potential positive catalyst for the stock beyond the headline numbers.
Key Takeaway: The most notable item is John Hess (Director, former Hess CEO) selling 575,000 shares via trust in two tranches (May 6 and May 20) totaling ~$107M — these are discretionary trust sales (not 10b5-1 plans), which warrants attention given the size, though the context is likely post-merger estate/trust management rather than a negative signal on CVX's outlook. All other transactions are routine director compensation grants.
Name | Title | Transaction Type | Shares / Value | Date | Note |
HESS JOHN B | Director | Open Market Sale (By Trust) | 195,000 shares (~$35.4M at ~$181.62) | May 6, 2026 | Discretionary trust sale; no 10b5-1 plan disclosed. Likely post-merger estate/trust management. Largest single transaction in the period. |
HESS JOHN B | Director | Open Market Sale (By Trust) | 380,000 shares (~$72.7M at ~$191.33) | May 20, 2026 | Discretionary trust sale; no 10b5-1 plan disclosed. Second large tranche within 2 weeks of first sale. Combined with May 6 sale: 575,000 shares / ~$108M. |
Austin Wanda M | Director | Award (Compensation Grant) | 1,272 shares | May 27, 2026 | Routine annual director equity compensation grant. No open-market purchase. |
Frank John | Director | Award (Compensation Grant) | 1,272 shares | May 27, 2026 | Routine annual director equity compensation grant. |
HERNANDEZ ENRIQUE JR | Director | Award (Compensation Grant) | 1,272 shares | May 27, 2026 | Routine annual director equity compensation grant. |
HESS JOHN B | Director | Award (Compensation Grant) | 1,272 shares | May 27, 2026 | Routine annual director equity compensation grant (separate from trust sales above). |
HEWSON MARILLYN A | Director | Award (Compensation Grant) | 1,272 shares (May 27) + 209 Phantom Stock (June 1) | May 27 & June 1, 2026 | Routine director compensation grants (equity + phantom stock). |
HORTON THOMAS W | Director | Award (Compensation Grant) | 1,272 shares | May 27, 2026 | Routine annual director equity compensation grant. |
Huntsman Jon M Jr | Director | Award (Compensation Grant) | 1,272 shares | May 27, 2026 | Routine annual director equity compensation grant. |
Moyo Dambisa F | Director | Award (Compensation Grant) + Gift (May 6) | 1,272 shares (May 27) + 780 shares gifted (May 6) | May 6 & May 27, 2026 | Routine grant + charitable gift (Form 4 code G). Not an open-market sale. |
REED DEBRA L | Director | Award (Compensation Grant) | 1,272 shares | May 27, 2026 | Routine annual director equity compensation grant. |
Umpleby III Donald J | Director | Award (Compensation Grant) | 1,272 shares | May 27, 2026 | Routine annual director equity compensation grant. |
WARNER CYNTHIA J | Director | Award (Compensation Grant) | 1,272 shares (May 27) + 20 Phantom Stock (June 1) | May 27 & June 1, 2026 | Routine director compensation grants (equity + phantom stock). |
Source: Insider Transaction Data (SEC Form 4 filings). Open-market buys and sells only (Form 4 codes P/S) plus compensation awards (code A) and gifts (code G) shown for completeness. No open-market purchases by any insider in the period. The John Hess trust sales (575,000 shares / ~$108M combined) are the only material discretionary transactions; context is likely post-Hess acquisition estate/trust restructuring rather than a negative signal on CVX's outlook. No 10b5-1 plans were disclosed for any transaction in the period. No executive officer (C-suite) open-market transactions were filed.
— End of Report —